Search Results - "Coughlan, Christina M."

Refine Results
  1. 1

    The burden of trisomy 21 disrupts the proteostasis network in Down syndrome by Aivazidis, Stefanos, Coughlan, Christina M, Rauniyar, Abhishek K, Jiang, Hua, Liggett, L Alexander, Maclean, Kenneth N, Roede, James R

    Published in PloS one (21-04-2017)
    “…Down syndrome (DS) is a genetic disorder caused by trisomy of chromosome 21. Abnormalities in chromosome number have the potential to lead to disruption of the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations by Caneus, Julbert, Granic, Antoneta, Rademakers, Rosa, Dickson, Dennis W, Coughlan, Christina M, Chial, Heidi J, Potter, Huntington

    Published in Molecular biology of the cell (01-03-2018)
    “…Mutant Tau (MAPT) can lead to frontotemporal lobar degeneration (FTLD). Previous studies associated MAPT mutations and altered function with aneuploidy and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Degradation of Mutated Bovine Pancreatic Trypsin Inhibitor in the Yeast Vacuole Suggests Post-endoplasmic Reticulum Protein Quality Control by Coughlan, Christina M., Walker, Jennifer L., Cochran, Jared C., Wittrup, K. Dane, Brodsky, Jeffrey L.

    Published in The Journal of biological chemistry (09-04-2004)
    “…The rate-limiting step in protein secretion is folding, which occurs in the endoplasmic reticulum (ER) lumen, and almost all secreted proteins contain…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Proteasome activity modulates amyloid toxicity by Galvin, John, Curran, Elizabeth, Arteaga, Francisco, Goossens, Alicia, Aubuchon-Endsley, Nicki, McMurray, Michael A, Moore, Jeffrey, Hansen, Kirk C, Chial, Heidi J, Potter, Huntington, Brodsky, Jeffrey L, Coughlan, Christina M

    Published in FEMS yeast research (09-03-2022)
    “…Abstract Alzheimer's disease (AD) is responsible for 60%–80% of identified cases of dementia. While the generation and accumulation of amyloid precursor…”
    Get full text
    Journal Article
  9. 9

    Granulocyte‐macrophage colony‐stimulating factor reverses Alzheimer’s disease pathology in the tgf344‐AD rat model by Ahmed, Md. Mahiuddin, Wang, Athena Ching‐Jung, Boyd, Timothy D., Solano, D. Adriana, Vielle, Anne, Markham, Neil, Coughlan, Christina M, Chial, Heidi J, Vergara, M. Natalia, Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), a hematopoietic growth factor, has shown therapeutic and neuroprotective effects in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast by Sparvero, Louis J., Patz, Sarah, Brodsky, Jeffrey L., Coughlan, Christina M.

    Published in Analytical biochemistry (15-11-2007)
    “…The accumulation and aggregation of fragments of amyloid precursor protein (APP) are central to the development of Alzheimer’s disease. The production of the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Increased Plasma brain‐derived neurotrophic factor (BDNF) as a Biomarker for Differentiating Mild Cognitive Impairment from Cognitive Healthy: A case‐control study by Ng, Ted Kheng Siang, Coughlan, Christina M, Heyn, Patricia C, Tagawa, Alex, Carollo, James, Kua, Ee‐Heok, Mahendran, Rathi

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Across the spectrum of Alzheimer’s disease (AD), we previously conducted a meta‐analysis and concluded significantly decreased brain‐derived…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Inflammation and innate immune system activation in neurodegeneration, Down syndrome, aging, and infection: Therapeutic target or partner? by Potter, Huntington, Boyd, Timothy D., Ahmed, Md. Mahiuddin, Kendall, Lon V., Sillau, Stefan H, Coughlan, Christina M, Clarke, Penny, Stonedahl, Sarah, Chial, Heidi J

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Characteristic features/biomarkers of innate immune system activation and inflammation are associated with neurodegenerative diseases (e.g.,…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Small molecule inhibitors of apolipoprotein E4‐catalyzed amyloid‐β fibrillization as novel therapeutics for Alzheimer’s disease by Johnson, Noah R., Wang, Athena Ching‐Jung, Coughlan, Christina M., Lucero, Esteban M., Viltz, Lisa, Allen, Cody, Markham, Neil, Chial, Heidi J., Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2020)
    “…Background Alzheimer’s disease (AD) is a progressive neurodegenerative illness initiated by fibrillization of the amyloid‐beta (Aβ) peptide in the brain…”
    Get full text
    Journal Article